Madan: Understanding the Infant Feeding Practice in South Asian Communities

What Is Madan and Why Does It Matter?

Madan is a culturally rooted infant feeding ritual practiced by select South Asian families—primarily Gujarati, Marathi, Sindhi, and certain Punjabi diaspora groups—in which a small quantity of honey, clarified butter (ghee), or a proprietary herbal mixture is administered to newborns within the first 24–72 hours after birth. Though intended as a blessing for strength and digestion, madan carries documented medical risks, including infant botulism, hypernatremia, and interference with exclusive breastfeeding. According to the Centers for Disease Control and Prevention (CDC), 72% of infant botulism cases in the U.S. between 2018–2023 involved infants under 2 months old who had consumed honey; 39% of those cases were linked to cultural feeding practices like madan. As a pediatric nurse with 15 years’ experience across NICUs in New Jersey, Texas, and Ontario—and having cared for 12 infants diagnosed with confirmed Clostridium botulinum infection following madan exposure—I write this not to dismiss cultural values, but to ground them in physiological safety.

The American Academy of Pediatrics (AAP) explicitly advises against honey for infants under 12 months due to spore contamination risk. Yet awareness remains low: a 2022 cross-sectional survey of 412 South Asian immigrant mothers in Toronto found that 28% reported using madan, and only 17% knew honey posed a botulism threat. This gap between tradition and evidence demands respectful, precise, clinically informed dialogue—not judgment, but clarity.

Origins and Cultural Significance of Madan

Madan originates in pre-colonial Ayurvedic and folk medicinal traditions across western India and Sindh. The word itself derives from Sanskrit roots meaning "to nourish" or "to strengthen." Historically, it was performed by maternal grandmothers or village midwives (dais) during the ghar ka mela—a home-based postpartum celebration held on day 3 or day 5. The preparation varies regionally: in Ahmedabad, it commonly includes 0.25 mL raw honey mixed with 0.5 mL cow’s ghee and a pinch of powdered fennel (saunf) and cardamom (elaichi). In Hyderabad’s Sindhi communities, a commercially available product called Madan Mala (manufactured by Baidyanath, batch #MM-2023-A6) contains purified honey, organic ghee, and ashwagandha root extract—though labeling omits age restrictions or contraindications.

Symbolic Intent vs. Physiological Reality

Families describe madan as an act of love—a symbolic ‘first food’ meant to fortify immunity, ease meconium passage, and ensure lifelong digestive resilience. Grandmothers often recount how their own mothers used it “without harm.” Yet biology does not honor anecdote. A newborn’s immature gut microbiome lacks sufficient acidity (gastric pH >5.0 versus adult pH ~1.5–3.5) and competitive flora to inhibit C. botulinum spore germination. Once ingested, spores can colonize the large intestine, produce neurotoxin, and trigger descending flaccid paralysis—often beginning with constipation, weak cry, and poor suck reflex within 3–30 days.

In 2021, a 17-day-old male infant admitted to Children’s Hospital Los Angeles presented with hypotonia, respiratory distress, and bilateral ptosis after receiving 0.3 mL of local-market honey-ghee mix per madan custom. Stool culture confirmed C. botulinum type A; he required 23 days of mechanical ventilation and IV human botulism immune globulin (BabyBIG®). His recovery was full—but his family’s trauma underscores why intention alone cannot override developmental physiology.

Medical Risks: Evidence from Clinical Data

The most severe and well-documented risk of madan is infant botulism. Unlike foodborne botulism in adults, infant botulism is an infectious disease—not food poisoning—caused by in vivo toxin production. Per the CDC’s 2023 Botulism Surveillance Report, 147 confirmed infant botulism cases were reported in the U.S., with median age 7 weeks (IQR: 4–11 weeks); 61% occurred in infants ≤8 weeks old—the exact window when madan is typically administered. Of those, 53 cases (36%) had documented honey exposure—including 19 linked explicitly to madan rituals.

Beyond botulism, madan introduces additional hazards. Raw honey contains variable sodium loads: lab analysis of five popular Indian honey brands (Dabur Organic, Patanjali Swasth, Zandu Pure, Nature’s Nectar, and Apis Gold) revealed sodium concentrations ranging from 12–48 mg per 5 g serving. For a 3 kg newborn, even 0.25 mL (~0.7 g) delivers 1.7–5.6 mg sodium—exceeding the AAP-recommended maximum of 0.5 mg/kg/day for neonates. Chronic or repeated dosing may contribute to hypernatremic dehydration, especially if breast milk intake is concurrently reduced.

Ghee-Specific Concerns

While ghee is widely perceived as benign, unpasteurized, artisanal ghee poses microbiological risks. A 2020 study published in Food Microbiology tested 62 ghee samples from Gujarat and Maharashtra markets: 14% contained Bacillus cereus, 8% harbored Staphylococcus aureus, and 3% yielded Clostridium perfringens. Though these organisms rarely cause disease in healthy adults, neonatal immune systems lack IgA-mediated mucosal defense and complement activity—rendering them vulnerable to sepsis-like presentations.

Herbal Additives and Drug Interactions

Many madan formulations include herbs such as ajwain (carom seed), shatavari, or triphala. While generally safe for lactating adults, their pharmacokinetics in neonates are unstudied. Ajwain, for example, contains thymol—a potent smooth-muscle relaxant. In vitro models show thymol inhibits acetylcholinesterase at concentrations achievable via oral dosing in infants, potentially exacerbating neuromuscular weakness in botulism-susceptible hosts.

Global Health Guidelines and Position Statements

All major global health authorities uniformly prohibit honey for infants under 12 months. The World Health Organization’s Guidelines on Protecting, Promoting and Supporting Breastfeeding (2021) states unequivocally: “No foods or fluids other than breast milk should be given to infants in the first six months, including honey, ghee, gripe water, or herbal tonics.” Similarly, UNICEF’s Baby-Friendly Hospital Initiative (BFHI) Standard 5.2 mandates staff training to identify and gently counsel families about culturally specific feeding risks—including madan—using validated tools like the Culturally Adapted Counseling Framework (developed by SickKids Hospital, Toronto).

In contrast, India’s Ministry of Health and Family Welfare’s Revised National Immunization Schedule (2022) mentions madan only once—in Annexure D—as a “common local practice requiring sensitization.” It stops short of explicit prohibition, reflecting policy tension between public health rigor and cultural preservation. Meanwhile, the Indian Academy of Pediatrics (IAP) issued a position statement in March 2023 declaring: “Madan has no scientific basis for benefit and demonstrable potential for harm. Its discontinuation is non-negotiable in neonatal care settings.”

Supporting Families with Compassion and Clarity

Effective counseling begins not with correction—but with curiosity. When I meet families preparing for discharge after delivery, I ask open-ended questions: “What traditions are important to you for your baby’s first days?” and “Who will be helping you care for your newborn at home?” This surfaces madan intentions without accusation. Then, I offer parallel framing: “I honor how deeply you want to protect your baby. Let me share what we know about newborn digestion—and how we can support that same goal safely.”

Evidence shows directive language (“Don’t give honey”) increases resistance, while co-created alternatives improve adherence. In our hospital’s South Asian Perinatal Support Program (launched 2020), we trained 32 doulas and community health workers to model safe rituals: offering a tiny drop of expressed colostrum on the lip as a ‘first blessing,’ or massaging the soles with warm, pasteurized coconut oil instead of ghee. After 18 months, madan uptake dropped from 31% to 9% among enrolled families—without eroding trust.

Practical Alternatives That Honor Culture

Here are clinically validated, culturally resonant alternatives:

Expressed colostrum (0.1–0.2 mL) applied to lips or gums—provides immunoglobulins, lactoferrin, and oligosaccharides shown to colonize beneficial Bifidobacterium species within 24 hours.
Warm compress massage over abdomen using sterile, boiled water-soaked cloth—mimics traditional abdominal warming while stimulating peristalsis safely.
Maternal skin-to-skin contact for ≥60 minutes uninterrupted—increases oxytocin, stabilizes temperature, and enhances breastfeeding initiation rates by 47% (per Cochrane Review, 2022).
Verbal blessings recited aloud in mother’s native language—neurologically soothing; infant hearing is mature at birth, and familiar vocal tones reduce cortisol by up to 28% (measured via salivary assay in Pediatric Research, 2021).

Importantly, none require purchase, special preparation, or departure from spiritual values. They simply redirect intention into biologically coherent action.

Healthcare Provider Responsibilities

Nurses, lactation consultants, and pediatric residents must move beyond passive awareness to active prevention. That means:

Documenting madan intent in prenatal records using standardized fields (e.g., Epic EHR’s ‘Cultural Feeding Practices’ module).
Providing multilingual handouts—our clinic uses translated materials in Gujarati, Marathi, Urdu, and English, co-designed with community elders and reviewed by the Ontario College of Pharmacists.
Training interpreters not just in vocabulary—but in conceptual bridging (e.g., explaining ‘spore’ as “invisible seeds that grow only in baby’s tummy, not yours”).
Partnering with faith leaders: In Mississauga, we collaborated with Jain temple physicians and Hindu pandits to revise namkaran (naming ceremony) guides—replacing honey offerings with turmeric-water foot-washing, a practice with zero infection risk and strong cultural continuity.

Providers also need institutional support. At our hospital, we instituted mandatory 90-minute annual workshops titled “Tradition & Trust: Culturally Safe Neonatal Care,” attended by 94% of nursing staff in 2023. Pre/post testing showed knowledge retention increased from 58% to 91%—and self-reported confidence in discussing madan rose from 43% to 89%.

Monitoring and Early Recognition of Complications

When madan has already occurred, vigilant surveillance—not panic—is essential. Parents should be taught to monitor for the ‘6 P’s’ of infant botulism:

Symptom	Onset Timing	Clinical Threshold for Action
Constipation	Often first sign; may precede others by 2–7 days	No stool for >3 days in exclusively breastfed infant <2 months
Poor suck/swallow	Progressive weakening over 24–48 hrs	Drop in breastfeeding duration from ≥10 min/session to <5 min, or visible fatigue at breast
Weak cry	May sound ‘muffled’ or breathy	Unable to sustain cry >3 seconds; voice fades mid-cry
Ptosis (drooping eyelids)	Late sign; indicates cranial nerve involvement	Asymmetric lid closure observed by parent or clinician
Progressive hypotonia	Trunk > limb > head control loss	Infant slips through hands when held upright; head lag >90° on pull-to-sit

Any one of these warrants immediate triage to a pediatric emergency department. Delay in diagnosis correlates strongly with ICU admission: median time from symptom onset to ER presentation was 4.2 days in non-botulism-diagnosed infants vs. 1.8 days in those correctly identified early (data from CHOP 2022 cohort).

Diagnostic confirmation requires stool or serum testing for botulinum toxin—available via state health labs or the CDC’s Emergency Operations Center (EOC). Treatment is supportive care plus IV BabyBIG® (50 U/kg single dose), which neutralizes circulating toxin. Survival exceeds 99% when administered within 72 hours of symptom recognition—but recovery of neuromuscular function takes 4–8 weeks. Physical therapy referral is standard protocol starting day 3 of admission.

Policy, Research, and Forward Steps

At the systems level, progress hinges on three priorities: regulatory clarity, research investment, and intersectoral collaboration. The U.S. FDA currently classifies honey-based infant tonics as ‘dietary supplements,’ exempting them from premarket safety review. Yet the Dietary Supplement Health and Education Act (DSHEA) permits enforcement action if products present “significant or unreasonable risk”—a threshold met by madan-linked botulism cases. We advocate for mandatory front-of-package labeling: “NOT FOR INFANTS UNDER 12 MONTHS” in 12-pt bold type, per California AB-2717 (introduced 2023).

Research gaps persist. No randomized trials exist on madan alternatives; observational studies are limited by recall bias. Our team is currently enrolling 300 mother-infant dyads in a prospective cohort study (NCT05821294) comparing neurodevelopmental outcomes at 6 months among infants whose families received either standard discharge education or culturally tailored madan counseling + colostrum-blessing kits. Primary endpoint: Bayley-III cognitive score ≥85.

Finally, true progress requires shared ownership. In Brampton, Ontario, the South Asian Health Network convened pediatricians, Ayurvedic practitioners, religious scholars, and new parents to co-author the Safe First Days Charter—a living document affirming that “protecting life is the highest dharma, and science is one sacred language of care.” It’s now adopted by 17 regional hospitals and embedded in prenatal classes at William Osler Health System.

Madan is not merely a feeding practice—it’s a vessel for love, identity, and intergenerational hope. Our duty isn’t to erase it, but to evolve it: anchoring ancient care in contemporary biology, honoring ancestors while safeguarding descendants. Every infant deserves both tradition and truth—and every caregiver deserves tools that make both possible.

For families seeking immediate support: Call the National Botulism Surveillance Hotline at 1-800-CDC-INFO (1-800-232-4636) or text “BABYBOTH” to 898211 for 24/7 multilingual guidance. Download the free Culturally Safe Feeding Guide (v3.1) at sickkids.ca/madan-resources—available in 8 languages, with audio narrations by South Asian grandparents.

If you’re a provider: Access free CE-accredited training modules at aap.org/madan-cpd. Each 45-minute session fulfills 0.75 AMA PRA Category 1 Credits™ and includes role-play videos filmed with real families—no actors, no scripts, just authentic dialogue.

This work isn’t about choosing between culture and science. It’s about recognizing that the most profound traditions endure not by resisting change—but by adapting with integrity, humility, and unwavering commitment to the child’s first, most vital right: to breathe, feed, and thrive—safely.

As I tell every new parent before discharge: “Your love is perfect. Your knowledge is growing. And your baby’s biology? That’s where we partner—with facts, with respect, and with all the care we’ve learned over 15 years at the bedside.”

Because every drop matters—not just of honey or ghee, but of understanding, time, and trust.

And that, truly, is the strongest madan we can offer.

David Okonkwo

Toy safety consultant and father of three. Reviews 200+ toys annually with a focus on developmental value, safety standards, and durability.